Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment

Gespeichert in:

Autor*in:	Frey, Reiner [verfasserIn] Becker, Corina Unger, Sigrun Schmidt, Anja Wensing, Georg Mueck, Wolfgang

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Schlagwörter:	Pulmonary Hypertension Liver Cirrhosis Hepatic Impairment Oral Tablet Moderate Hepatic Impairment

Anmerkung:	© Frey et al; licensee BioMed Central Ltd. 2013

Übergeordnetes Werk:	Enthalten in: BMC pharmacology & toxicology - London : BioMed Central, 2012, 14(2013), Suppl 1 vom: 29. Aug.
Übergeordnetes Werk:	volume:14 ; year:2013 ; number:Suppl 1 ; day:29 ; month:08

Links:	Volltext

DOI / URN:	10.1186/2050-6511-14-S1-P21

Katalog-ID:	SPR036373524

Internformat


LEADER	01000caa a22002652 4500
001	SPR036373524
003	DE-627
005	20230520003437.0
007	cr uuu---uuuuu
008	201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/2050-6511-14-S1-P21 \|2 doi
035			\|a (DE-627)SPR036373524
035			\|a (SPR)2050-6511-14-S1-P21-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Frey, Reiner \|e verfasserin \|4 aut
245	1	0	\|a Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
264		1	\|c 2013
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Frey et al; licensee BioMed Central Ltd. 2013
650		4	\|a Pulmonary Hypertension \|7 (dpeaa)DE-He213
650		4	\|a Liver Cirrhosis \|7 (dpeaa)DE-He213
650		4	\|a Hepatic Impairment \|7 (dpeaa)DE-He213
650		4	\|a Oral Tablet \|7 (dpeaa)DE-He213
650		4	\|a Moderate Hepatic Impairment \|7 (dpeaa)DE-He213
700	1		\|a Becker, Corina \|4 aut
700	1		\|a Unger, Sigrun \|4 aut
700	1		\|a Schmidt, Anja \|4 aut
700	1		\|a Wensing, Georg \|4 aut
700	1		\|a Mueck, Wolfgang \|4 aut
773	0	8	\|i Enthalten in \|t BMC pharmacology & toxicology \|d London : BioMed Central, 2012 \|g 14(2013), Suppl 1 vom: 29. Aug. \|w (DE-627)723899754 \|w (DE-600)2680259-4 \|x 2050-6511 \|7 nnns
773	1	8	\|g volume:14 \|g year:2013 \|g number:Suppl 1 \|g day:29 \|g month:08
856	4	0	\|u https://dx.doi.org/10.1186/2050-6511-14-S1-P21 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 14 \|j 2013 \|e Suppl 1 \|b 29 \|c 08

Indexfelder

author_variant	r f rf c b cb s u su a s as g w gw w m wm
matchkey_str	article:20506511:2013----::hraoieisfhslbeunltccaetmltricgaiidvd
hierarchy_sort_str	2013
publishDate	2013
allfields	10.1186/2050-6511-14-S1-P21 doi (DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e DE-627 ger DE-627 rakwb eng Frey, Reiner verfasserin aut Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Frey et al; licensee BioMed Central Ltd. 2013 Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213 Becker, Corina aut Unger, Sigrun aut Schmidt, Anja aut Wensing, Georg aut Mueck, Wolfgang aut Enthalten in BMC pharmacology & toxicology London : BioMed Central, 2012 14(2013), Suppl 1 vom: 29. Aug. (DE-627)723899754 (DE-600)2680259-4 2050-6511 nnns volume:14 year:2013 number:Suppl 1 day:29 month:08 https://dx.doi.org/10.1186/2050-6511-14-S1-P21 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2013 Suppl 1 29 08
spelling	10.1186/2050-6511-14-S1-P21 doi (DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e DE-627 ger DE-627 rakwb eng Frey, Reiner verfasserin aut Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Frey et al; licensee BioMed Central Ltd. 2013 Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213 Becker, Corina aut Unger, Sigrun aut Schmidt, Anja aut Wensing, Georg aut Mueck, Wolfgang aut Enthalten in BMC pharmacology & toxicology London : BioMed Central, 2012 14(2013), Suppl 1 vom: 29. Aug. (DE-627)723899754 (DE-600)2680259-4 2050-6511 nnns volume:14 year:2013 number:Suppl 1 day:29 month:08 https://dx.doi.org/10.1186/2050-6511-14-S1-P21 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2013 Suppl 1 29 08
allfields_unstemmed	10.1186/2050-6511-14-S1-P21 doi (DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e DE-627 ger DE-627 rakwb eng Frey, Reiner verfasserin aut Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Frey et al; licensee BioMed Central Ltd. 2013 Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213 Becker, Corina aut Unger, Sigrun aut Schmidt, Anja aut Wensing, Georg aut Mueck, Wolfgang aut Enthalten in BMC pharmacology & toxicology London : BioMed Central, 2012 14(2013), Suppl 1 vom: 29. Aug. (DE-627)723899754 (DE-600)2680259-4 2050-6511 nnns volume:14 year:2013 number:Suppl 1 day:29 month:08 https://dx.doi.org/10.1186/2050-6511-14-S1-P21 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2013 Suppl 1 29 08
allfieldsGer	10.1186/2050-6511-14-S1-P21 doi (DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e DE-627 ger DE-627 rakwb eng Frey, Reiner verfasserin aut Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Frey et al; licensee BioMed Central Ltd. 2013 Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213 Becker, Corina aut Unger, Sigrun aut Schmidt, Anja aut Wensing, Georg aut Mueck, Wolfgang aut Enthalten in BMC pharmacology & toxicology London : BioMed Central, 2012 14(2013), Suppl 1 vom: 29. Aug. (DE-627)723899754 (DE-600)2680259-4 2050-6511 nnns volume:14 year:2013 number:Suppl 1 day:29 month:08 https://dx.doi.org/10.1186/2050-6511-14-S1-P21 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2013 Suppl 1 29 08
allfieldsSound	10.1186/2050-6511-14-S1-P21 doi (DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e DE-627 ger DE-627 rakwb eng Frey, Reiner verfasserin aut Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Frey et al; licensee BioMed Central Ltd. 2013 Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213 Becker, Corina aut Unger, Sigrun aut Schmidt, Anja aut Wensing, Georg aut Mueck, Wolfgang aut Enthalten in BMC pharmacology & toxicology London : BioMed Central, 2012 14(2013), Suppl 1 vom: 29. Aug. (DE-627)723899754 (DE-600)2680259-4 2050-6511 nnns volume:14 year:2013 number:Suppl 1 day:29 month:08 https://dx.doi.org/10.1186/2050-6511-14-S1-P21 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 14 2013 Suppl 1 29 08
language	English
source	Enthalten in BMC pharmacology & toxicology 14(2013), Suppl 1 vom: 29. Aug. volume:14 year:2013 number:Suppl 1 day:29 month:08
sourceStr	Enthalten in BMC pharmacology & toxicology 14(2013), Suppl 1 vom: 29. Aug. volume:14 year:2013 number:Suppl 1 day:29 month:08
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Pulmonary Hypertension Liver Cirrhosis Hepatic Impairment Oral Tablet Moderate Hepatic Impairment
isfreeaccess_bool	true
container_title	BMC pharmacology & toxicology
authorswithroles_txt_mv	Frey, Reiner @@aut@@ Becker, Corina @@aut@@ Unger, Sigrun @@aut@@ Schmidt, Anja @@aut@@ Wensing, Georg @@aut@@ Mueck, Wolfgang @@aut@@
publishDateDaySort_date	2013-08-29T00:00:00Z
hierarchy_top_id	723899754
id	SPR036373524
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036373524</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520003437.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2050-6511-14-S1-P21</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036373524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2050-6511-14-S1-P21-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Frey, Reiner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Frey et al; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pulmonary Hypertension</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liver Cirrhosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatic Impairment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Tablet</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Moderate Hepatic Impairment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Becker, Corina</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Unger, Sigrun</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmidt, Anja</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wensing, Georg</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mueck, Wolfgang</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">BMC pharmacology & toxicology</subfield><subfield code="d">London : BioMed Central, 2012</subfield><subfield code="g">14(2013), Suppl 1 vom: 29. Aug.</subfield><subfield code="w">(DE-627)723899754</subfield><subfield code="w">(DE-600)2680259-4</subfield><subfield code="x">2050-6511</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:29</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2050-6511-14-S1-P21</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">29</subfield><subfield code="c">08</subfield></datafield></record></collection>
author	Frey, Reiner
spellingShingle	Frey, Reiner misc Pulmonary Hypertension misc Liver Cirrhosis misc Hepatic Impairment misc Oral Tablet misc Moderate Hepatic Impairment Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
authorStr	Frey, Reiner
ppnlink_with_tag_str_mv	@@773@@(DE-627)723899754
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2050-6511
topic_title	Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment Pulmonary Hypertension (dpeaa)DE-He213 Liver Cirrhosis (dpeaa)DE-He213 Hepatic Impairment (dpeaa)DE-He213 Oral Tablet (dpeaa)DE-He213 Moderate Hepatic Impairment (dpeaa)DE-He213
topic	misc Pulmonary Hypertension misc Liver Cirrhosis misc Hepatic Impairment misc Oral Tablet misc Moderate Hepatic Impairment
topic_unstemmed	misc Pulmonary Hypertension misc Liver Cirrhosis misc Hepatic Impairment misc Oral Tablet misc Moderate Hepatic Impairment
topic_browse	misc Pulmonary Hypertension misc Liver Cirrhosis misc Hepatic Impairment misc Oral Tablet misc Moderate Hepatic Impairment
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	BMC pharmacology & toxicology
hierarchy_parent_id	723899754
hierarchy_top_title	BMC pharmacology & toxicology
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)723899754 (DE-600)2680259-4
title	Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
ctrlnum	(DE-627)SPR036373524 (SPR)2050-6511-14-S1-P21-e
title_full	Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
author_sort	Frey, Reiner
journal	BMC pharmacology & toxicology
journalStr	BMC pharmacology & toxicology
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2013
contenttype_str_mv	txt
author_browse	Frey, Reiner Becker, Corina Unger, Sigrun Schmidt, Anja Wensing, Georg Mueck, Wolfgang
container_volume	14
format_se	Elektronische Aufsätze
author-letter	Frey, Reiner
doi_str_mv	10.1186/2050-6511-14-S1-P21
title_sort	pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
title_auth	Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
abstract	© Frey et al; licensee BioMed Central Ltd. 2013
abstractGer	© Frey et al; licensee BioMed Central Ltd. 2013
abstract_unstemmed	© Frey et al; licensee BioMed Central Ltd. 2013
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	Suppl 1
title_short	Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
url	https://dx.doi.org/10.1186/2050-6511-14-S1-P21
remote_bool	true
author2	Becker, Corina Unger, Sigrun Schmidt, Anja Wensing, Georg Mueck, Wolfgang
author2Str	Becker, Corina Unger, Sigrun Schmidt, Anja Wensing, Georg Mueck, Wolfgang
ppnlink	723899754
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1186/2050-6511-14-S1-P21
up_date	2024-07-03T17:14:06.869Z
_version_	1803578870986702849
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036373524</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230520003437.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2050-6511-14-S1-P21</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036373524</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2050-6511-14-S1-P21-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Frey, Reiner</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Frey et al; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pulmonary Hypertension</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Liver Cirrhosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatic Impairment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral Tablet</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Moderate Hepatic Impairment</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Becker, Corina</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Unger, Sigrun</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmidt, Anja</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wensing, Georg</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mueck, Wolfgang</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">BMC pharmacology & toxicology</subfield><subfield code="d">London : BioMed Central, 2012</subfield><subfield code="g">14(2013), Suppl 1 vom: 29. Aug.</subfield><subfield code="w">(DE-627)723899754</subfield><subfield code="w">(DE-600)2680259-4</subfield><subfield code="x">2050-6511</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:29</subfield><subfield code="g">month:08</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2050-6511-14-S1-P21</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">29</subfield><subfield code="c">08</subfield></datafield></record></collection>
score	7.4019604

Nicht das Richtige dabei?

Schreiben Sie uns!

Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?